NEXT GENERATION ONCOLOGY & COMPREHENSIVE NEXT GENERATION PROFILING TESTS
Next generation profiling tests helps to find Personalized Test Solutions for a new roadmap in cancer management and treatment. Molecular profiling tests provide physicians with the most up-to-date diagnostic and treatment options for their patients by utilizing next-generation genetic technologies and scientific data.
These oncological tests are suitable for analyzing both solid tumors from paraffin blocks and liquid biopsies.
Here are the most comprehensive tests in the diagnosis and management of cancer:
- Onkogenetiks CGP (Comprehensive Genomic Profiling)
- Onkogenetiks Molecular Profiling and Tumor Mutation Burden (TMB)
- Onkogenetiks Fusion Panel
- Onkogenetiks Liquid Biopsy
- Onkogenetiks Hereditary Cancer Panel
- Onkogenetiks Breast and Ovary Cancer Panel
- Onkogenetiks HematoMAP Myeloid Panel
CONVENTIONAL ONCOLOGY & TARGETED TESTS for
- Lung Carcinoma
- Breast Carcinoma
- Colon Carcinoma
- Oligodendroglioma
- Gastrointestinal Carcinoma
- Malignant Melanoma
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Myeloid Leukemia (CML)
Key Genes Involved in Cancer Pathogenesis
Critical genes such as NRAS, KRAS, HRAS, BRAF, FLT3, JAK2, EGFR, IDH1, IDH2, BRCA1, BRCA2, HER2, and BCR-ABL can be screened in a targeted manner using cytogenetic and molecular tests, including FISH, real-time PCR, MLPA, Sanger sequencing, and NGS.